2m 2m 2m 2m 2m 2m 2m
TURN THERAPEUTIC (TTRX)
NASDAQ
$13.25-$0.08 (-0.62%)
Price as of Oct 02, 2026 7:50 PM EDT- $404.8MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
TURN THERAPEUTIC (TTRX)
$13.25-$0.08 (-0.62%)
TTRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.33 | ||
Change | +$0.02 (+0.15%) | ||
Open | $13.35 | ||
High | $13.48 | ||
Low | $12.17 | ||
Previous Close | $13.31 | ||
Volume | 136,298 | ||
30-Day Average Volume | 175,088 | ||
1-Week Change | 6.73% | ||
1-Month Change | 37.85% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 30.4M | ||
Total Assets | $17.0M | ||
Market Cap | $404.8M | ||
Enterprise Value | $400.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.8M | ||
Free Cash Flow | -$923,364.00 | ||
EBIT | -$5.6M | ||
EBITDA | -$5.6M | ||
Net Working Capital | $1.7M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -72 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -67 | ||
PEG | 0 | ||
Price/Free Cash Flow | -438 | ||
Price/Operating Cash Flow | -438 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue